Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Dasiglucagon, a next-generation ready-to-use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: Results of a phase 3, randomized controlled trial.
Pediatr Diabetes. 2021 Aug;22(5):734-741. doi: 10.1111/pedi.13220. Epub 2021 Jun 9.
Pediatr Diabetes. 2021.
PMID: 33934456
Free PMC article.
Clinical Trial.
Dasiglucagon, a next-generation glucagon analogue, for treatment of severe hypoglycaemia via an autoinjector device: Results of a phase 3, randomized, double-blind trial.
Bailey TS, Willard J, Klaff LJ, Yager Stone J, Melgaard A, Tehranchi R.
Bailey TS, et al. Among authors: yager stone j.
Diabetes Obes Metab. 2021 Oct;23(10):2329-2335. doi: 10.1111/dom.14475. Epub 2021 Jul 19.
Diabetes Obes Metab. 2021.
PMID: 34169625
Clinical Trial.
Item in Clipboard
Cite
Cite